Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen deferred Tax Liabilities (DTL) — Total Gross DTL ($M) ($M)
Form 10-K Income Taxes Note (XBRL)
Latest, FY2025
3,238
Period ended Dec 31, 2025
Change on a year earlier
-3.0%
3,338 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Deferred Tax Liabilities (DTL) — Total Gross DTL ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,238 | -3.0% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 3,338 | -18.7% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 4,108 | +119.0% | Form 10-K (filed 2025-02-14) ↗ |
| FY2022 | Dec 31, 2022 | 1,876 | +29.5% | Form 10-K (filed 2024-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 1,449 | -4.8% | Form 10-K (filed 2023-02-09) ↗ |
| FY2020 | Dec 31, 2020 | 1,522 | -14.7% | Form 10-K (filed 2022-02-16) ↗ |
| FY2019 | Dec 31, 2019 | 1,784 | -9.0% | Form 10-K (filed 2021-02-09) ↗ |
| FY2018 | Dec 31, 2018 | 1,960 | -9.8% | Form 10-K (filed 2019-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 2,172 | -42.7% | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 3,791 | -1.8% | Form 10-K (filed 2018-02-13) ↗ |
| FY2015 | Dec 31, 2015 | 3,860 | – | Form 10-K (filed 2017-02-14) ↗ |
Breakdown
What makes up deferred tax liabilities (dtl) — total gross dtl ($m)
- DTL — Acquired Intangible Assets ($M)2,065 · FY2025
- DTL — Property, Plant & Equipment ($M)192 · FY2025
- DTL — Inventory Basis Differences ($M)28 · FY2025
- DTL — Debt & Financial Instruments ($M)260 · FY2025
- DTL — Investment Securities ($M)422 · FY2025
- DTL — Other Deferred Tax Liabilities ($M)271 · FY2025
- Net Deferred Tax Liabilities Recognized on Balance Sheet ($M)1,366 · FY2025
Cite this data
StockData. (2026). Amgen Deferred Tax Liabilities (DTL) — Total Gross DTL ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/dtl_gross
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.